U.S., Japan Regulators Begin Collaborative Review Pilot With Femoral Stents
This article was originally published in The Gray Sheet
Executive Summary
FDA and Japanese regulators recently began to work together to review two devices - one U.S.-manufactured, one Japanese-made - that are part of a new pilot program intended to model how products can achieve faster market entry in both countries
You may also be interested in...
Terumo Receives FDA Go-Ahead To Start Trial As Part Of U.S./Japan Pilot
Japanese device maker Terumo on May 12 announced it had received conditional U.S. FDA approval to begin enrollment for a U.S. clinical trial of its Misago superficial femoral artery stent
Terumo Receives FDA Go-Ahead To Start Trial As Part Of U.S./Japan Pilot
Japanese device maker Terumo on May 12 announced it had received conditional FDA approval to begin enrollment for a U.S. clinical trial of its Misago superficial femoral artery stent
Terumo Receives FDA Go-Ahead To Start Trial As Part Of U.S./Japan Pilot
Japanese device maker Terumo on May 12 announced it had received conditional FDA approval to begin enrollment for a U.S. clinical trial of its Misago superficial femoral artery stent